Results 321 to 330 of about 112,904 (357)

Impact of GLP‐1RA on the Risk of Adverse Liver Outcomes Among Patients With Alcohol‐Associated Liver Disease and Type 2 Diabetes

open access: yesLiver International, Volume 45, Issue 4, April 2025.
ABSTRACT Background and Aims We sought to characterise the impact of GLP‐1RA on adverse liver outcomes (ALO) among patients with alcohol‐associated liver disease (ALD) and Type 2 diabetes mellitus (T2DM). Methods Patients with T2DM newly diagnosed with ALD between 2013 and 2020 were identified using IBM MarketScan database and were categorised by GLP ...
Zayed Rashid   +9 more
wiley   +1 more source

Use of Proton Pump Inhibitors Among Patients With Alcohol‐Related Cirrhosis—A Danish Nationwide Cohort Study

open access: yesLiver International, Volume 45, Issue 4, April 2025.
ABSTRACT Background Use of proton pump inhibitors (PPIs) may have adverse effects in patients with alcohol‐related cirrhosis (ALD cirrhosis), but PPIs continue to be used by many patients. Aims We aimed to describe the prevalence and incidence of PPI use from filled prescriptions among patients with ALD cirrhosis and to identify predictors of PPI ...
Marine Sølling Ramsing   +2 more
wiley   +1 more source

Home - About - Disclaimer - Privacy